Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: April 9th - 30.5Mil plus 20Mil/yr for 7 more yrs.

From that same CE artile on Dec 10

<Turley says that the kind of technology they are looking for is groundbreaking hardware and/or software concepts in the embedded systems and microprocessor space. “We’re looking for something I can understand,” he quips.>

That may be what JT was looking for (he has not been waiting for years like many investors and board members), but did the BOD want some new untested/groundbreaking tech that might take additional years to develop? Or perhaps something less risky with more immediate impact on pps? I suspect there could have been disagreement with the rest of the board on this point. Opty

Share
New Message
Please login to post a reply